ZERO Cancer

Home  •  Elected Officials  •  Issues  •  Election  •  Media
Current Legislation
Key Bills in Congress See State Leg. Bills
Bill Name  Number of Sponsors  Position
S. 1190 - A bill to reduce disparities and improve access to effective and cost efficient diagnosis and treatment of prostate cancer through advances in testing, research, and education, including through telehealth, comparative effectiveness research, and identification of best practices in patient education and outreach particularly with respect to underserved racial, ethnic and rural populations and men with a family history of prostate cancer, to establish a directive on what constitutes clinically 8 (5 R, 3 D) We support this legislation
S.RES. 347 - S. Res 347 46 (12 R, 1 I, 33 D) -
H.R. 3790 - Improving Cancer Treatment Education Act of 2012 7 (1 R, 6 D) -
H.R. 3466 - Taxpayers' Funded Cancer Research Act 20 (9 R, 11 D) We support this legislation
H.R. 2159 - PROSTATE Act 36 (6 R, 30 D) We support this legislation
H.RES. 336 - Expressing support for designation of September 2011 as "National Prostate Cancer Awareness Month". 14 (6 R, 8 D) We support this legislation
H.RES. 313 - Recognizing that the occurrence of prostate cancer in African-American men has reached epidemic proportions and urging Federal agencies to address that health crisis by designating additional funds for research, education, awareness outreach, and early detection. 1 (1 D) We support this legislation

Congressional Bill Search: enter key word(s)

Senate House
Bill Number: Choose type, enter bill number
   



Tell-A-Friend

powered by CQ Roll Call ©2012

© 2012 ZERO - The Project to End Prostate Cancer. All Rights Reserved. Contact Us | Privacy Policy Powered by ARCOS | Design by Floyd & Partners

ZERO does not endorse any course of treatment for men with prostate cancer or other conditions. Treatment decisions should be made by a patient and his health service provider. If you have problems with the site or need more information, please call us at 1.888.245.9455 or e-mail your comments. All names, logos and articles are the copyrights of the respective owners.